dc.contributor.author |
Khoury D.E. |
dc.contributor.author |
Hwalla N. |
dc.contributor.author |
Frochot V. |
dc.contributor.author |
Lacorte J.-M. |
dc.contributor.author |
Chabert M. |
dc.contributor.author |
Kalopissis A.D. |
dc.contributor.editor |
|
dc.date |
2010 |
dc.date.accessioned |
2017-10-18T13:24:25Z |
dc.date.available |
2017-10-18T13:24:25Z |
dc.date.issued |
2010 |
dc.identifier |
10.1016/j.atherosclerosis.2009.11.017 |
dc.identifier.issn |
219150 |
dc.identifier.uri |
http://hdl.handle.net/10938/20269 |
dc.description.abstract |
Background: The metabolic syndrome (MS) is a cluster of heterogeneous abnormalities conferring increased risk of cardiovascular diseases. Few postprandial studies have been conducted in MS individuals. Objectives: We aimed to study MS subjects with the same abnormalities: abdominal obesity, hypertriglyceridemia and low plasma HDL. We assessed postprandial variations of metabolic parameters related to obesity, dyslipidemia and glucose homeostasis. Methods: In this randomized, double-blind, cross-over study, male MS and control subjects consumed, at separate occasions, a high carbohydrate (HC), high fat (HF) or high protein (HP) breakfast meal providing 30percent of each subject's resting energy expenditure. Results: Appetite hormones peptide YY and ghrelin did not differ between-subject groups. Interleukin-6 was two-fold higher in MS compared with control subjects, consistently with an inflammatory state. Hypertriglyceridemia of MS subjects was aggravated postprandially with the HF and HP meals and was lowest after the HC meal, arguing against increased hepatic VLDL production. HDL-cholesterol of MS subjects remained low postprandially, whereas apolipoprotein (apo) A-II was higher than in control subjects. Unexpectedly, postprandial insulin and glucose responses were higher in MS compared with control subjects, with the HP meal inducing the greater effects. Conclusions: The sustained postprandial hypertriglyceridemia of MS subjects after all meals suggests defective catabolism of triglyceride-rich lipoproteins. The greater postprandial increases in plasma insulin and glucose in MS relatively to control subjects indicate decreased insulin sensitivity, not revealed in the fasted state. © 2009. |
dc.format.extent |
|
dc.format.extent |
Pages: (307-313) |
dc.language |
English |
dc.publisher |
CLARE |
dc.relation.ispartof |
Publication Name: Atherosclerosis; Publication Year: 2010; Volume: 210; no. 1; Pages: (307-313); |
dc.source |
Scopus |
dc.title |
Postprandial metabolic and hormonal responses of obese dyslipidemic subjects with metabolic syndrome to test meals, rich in carbohydrate, fat or protein |
dc.type |
Article |
dc.contributor.affiliation |
Khoury, D.E., INSERM, U872, Centre de Recherche des Cordeliers, Equipe 4, F-75006 Paris, France, UPMC Univ Paris 06, UMR S 872, Equipe 4, F-75006 Paris, France, Université Paris Descartes, UMR S 872, Equipe 4, F-75006 Paris, France, American University of Beirut, Faculty of Agricultural and Food Sciences, Department of Nutrition and Food Sciences, Beirut, Lebanon |
dc.contributor.affiliation |
Hwalla, N., American University of Beirut, Faculty of Agricultural and Food Sciences, Department of Nutrition and Food Sciences, Beirut, Lebanon |
dc.contributor.affiliation |
Frochot, V., INSERM, U872, Centre de Recherche des Cordeliers, Equipe 4, F-75006 Paris, France, UPMC Univ Paris 06, UMR S 872, Equipe 4, F-75006 Paris, France, Université Paris Descartes, UMR S 872, Equipe 4, F-75006 Paris, France, Assistance Publique-Hôpitaux de Paris, Hôpital Pitié-Salpêtrière, Biochimie Endocrinienne et Oncologique, F-75013 Paris, France |
dc.contributor.affiliation |
Lacorte, J.-M., INSERM, U872, Centre de Recherche des Cordeliers, Equipe 4, F-75006 Paris, France, UPMC Univ Paris 06, UMR S 872, Equipe 4, F-75006 Paris, France, Université Paris Descartes, UMR S 872, Equipe 4, F-75006 Paris, France, Assistance Publique-Hôpitaux de Paris, Hôpital Pitié-Salpêtrière, Biochimie Endocrinienne et Oncologique, F-75013 Paris, France |
dc.contributor.affiliation |
Chabert, M., INSERM, U872, Centre de Recherche des Cordeliers, Equipe 4, F-75006 Paris, France, UPMC Univ Paris 06, UMR S 872, Equipe 4, F-75006 Paris, France, Université Paris Descartes, UMR S 872, Equipe 4, F-75006 Paris, France, EPHE, Laboratoire de Pharmacologie Cellulaire et Moléculaire, F-75006 Paris, France |
dc.contributor.affiliation |
Kalopissis, A.D., INSERM, U872, Centre de Recherche des Cordeliers, Equipe 4, F-75006 Paris, France, UPMC Univ Paris 06, UMR S 872, Equipe 4, F-75006 Paris, France, Université Paris Descartes, UMR S 872, Equipe 4, F-75006 Paris, France |
dc.contributor.authorAddress |
Kalopissis, A.D.; INSERM, U872, Centre de Recherche des Cordeliers, Rue de l'Ecole de Médecine, Equipe 4, 15, F-75006 Paris, France; email: athina.kalopissis@crc.jussieu.fr |
dc.contributor.authorCorporate |
University: American University of Beirut; Faculty: Faculty of Agricultural and Food Sciences; Department: Nutrition and Food Sciences; |
dc.contributor.authorDepartment |
Nutrition and Food Sciences |
dc.contributor.authorDivision |
|
dc.contributor.authorEmail |
athina.kalopissis@crc.jussieu.fr |
dc.contributor.Faculty |
Faculty of Agricultural and Food Sciences |
dc.contributor.authorInitials |
El Khoury, D |
dc.contributor.authorInitials |
Hwalla, N |
dc.contributor.authorInitials |
Frochot, V |
dc.contributor.authorInitials |
Lacorte, JM |
dc.contributor.authorInitials |
Chabert, M |
dc.contributor.authorInitials |
Kalopissis, AD |
dc.contributor.authorOrcidID |
|
dc.contributor.authorReprintAddress |
Kalopissis, AD (reprint author), Ctr Rech Cordeliers, INSERM, U872, Equipe 4, 15 Rue Ecole Med, F-75006 Paris, France. |
dc.contributor.authorResearcherID |
|
dc.contributor.authorUniversity |
American University of Beirut |
dc.description.cited |
Sibai Abla-Mehio, 2008, CVD Prevention and Control, V3, DOI 10.1016-j.precon.2007.06.002; Badman MK, 2007, GASTROENTEROLOGY, V132, P2103, DOI 10.1053-j.gastro.2007.03.058; Birjmohun RS, 2007, CIRCULATION, V116, P2029, DOI 10.1161-CIRCULATIONAHA.107.704031; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038-nature05817; Burdge GC, 2006, BRIT J NUTR, V96, P489, DOI 10.1079-BJN20061877; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056-NEJM199602013340503; DEGASQUET P, 1977, J NUTR, V107, P199; Dugue-Pujol S, 2006, J LIPID RES, V47, P2631, DOI 10.1194-jlr.M600112-JLR200; Fain JN, 2004, ENDOCRINOLOGY, V145, P2273, DOI 10.1210-en.2003-1336; Goldberg IJ, 1996, J LIPID RES, V37, P693; GREENBERG AS, 1992, CANCER RES, V52, P4113; Haffner SM, 2006, AM J CARDIOL, V97, p3A, DOI 10.1016-j.amjcard.2005.11.010; HIRANO T, 1989, AM J PHYSIOL, V256, pE559; Huuskonen J, 2001, ATHEROSCLEROSIS, V155, P269, DOI 10.1016-S0021-9150(01)00447-6; KALOPISSIS AD, 1982, BIOCHIM BIOPHYS ACTA, V711, P33, DOI 10.1016-0005-2760(82)90006-6; KALOPISSIS AD, 1995, METABOLISM, V44, P19, DOI 10.1016-0026-0495(95)90284-8; KORO CE, 2006, AM HEART J, V151; Kugiyama K, 1999, CIRCULATION, V99, P2858; Layman DK, 2004, J NUTR, V134, p968S; Nordmann AJ, 2006, ARCH INTERN MED, V166, P285, DOI 10.1001-archinte.166.3.285; Oussadou L, 1996, AM J PHYSIOL-ENDOC M, V271, pE952; Purnell JQ, 1997, CURR OPIN LIPIDOL, V8, P17, DOI 10.1097-00041433-199702000-00005; QUARFORD.SH, 1970, J CLIN INVEST, V49, P2281, DOI 10.1172-JCI106448; Rader DJ, 2006, J CLIN INVEST, V116, P3090, DOI 10.1172-JCI30163; Reaven GM, 1997, CURR OPIN LIPIDOL, V8, P23, DOI 10.1097-00041433-199702000-00006; REAVEN GM, 1993, ANNU REV MED, V44, P121, DOI 10.1146-annurev.med.44.1.121; Tai ES, 1999, DIABETES, V48, P1088, DOI 10.2337-diabetes.48.5.1088; TALL AR, 1978, NEW ENGL J MED, V299, P1232, DOI 10.1056-NEJM197811302992207; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038-nri1937; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172-JCI2000319246; Williams KJ, 2008, J CLIN INVEST, V118, P3247, DOI 10.1172-JCI35206; Wren AM, 2007, GASTROENTEROLOGY, V132, P2116, DOI 10.1053-j.gastro.2007.03.048; Zimmet P, 2005, J ATHEROSCLER THROMB, V12, P295 |
dc.description.citedCount |
27 |
dc.description.citedTotWOSCount |
1 |
dc.description.citedWOSCount |
1 |
dc.format.extentCount |
7 |
dc.identifier.articleNo |
|
dc.identifier.coden |
ATHSB |
dc.identifier.pubmedID |
20031131 |
dc.identifier.scopusID |
77952422545 |
dc.publisher.address |
ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND |
dc.relation.ispartOfISOAbbr |
Atherosclerosis |
dc.relation.ispartOfIssue |
1 |
dc.relation.ispartofPubTitle |
Atherosclerosis |
dc.relation.ispartofPubTitleAbbr |
Atherosclerosis |
dc.relation.ispartOfVolume |
210 |
dc.source.ID |
WOS:000277085300051 |
dc.type.publication |
Journal |
dc.subject.otherAuthKeyword |
Hdl |
dc.subject.otherAuthKeyword |
hypertriglyceridemia |
dc.subject.otherAuthKeyword |
insulin sensitivity |
dc.subject.otherAuthKeyword |
metabolic syndrome |
dc.subject.otherAuthKeyword |
postprandial period |
dc.subject.otherChemCAS |
Ghrelin, 258279-04-8, 304853-26-7 |
dc.subject.otherChemCAS |
glucose, 50-99-7, 84778-64-3 |
dc.subject.otherChemCAS |
insulin, 9004-10-8 |
dc.subject.otherChemCAS |
peptide yy, 81858-94-8 |
dc.subject.otherChemCAS |
apolipoprotein a-i |
dc.subject.otherChemCAS |
blood glucose |
dc.subject.otherChemCAS |
cholesterol, hdl |
dc.subject.otherChemCAS |
dietary carbohydrates |
dc.subject.otherChemCAS |
dietary fats |
dc.subject.otherChemCAS |
dietary proteins |
dc.subject.otherChemCAS |
ghrelin |
dc.subject.otherChemCAS |
insulin, 11061-68-0 |
dc.subject.otherChemCAS |
interleukin-6 |
dc.subject.otherChemCAS |
peptide yy, 106388-42-5 |
dc.subject.otherIndex |
Apolipoprotein |
dc.subject.otherIndex |
ghrelin |
dc.subject.otherIndex |
glucose |
dc.subject.otherIndex |
high density lipoprotein |
dc.subject.otherIndex |
insulin |
dc.subject.otherIndex |
interleukin 6 |
dc.subject.otherIndex |
peptide yy |
dc.subject.otherIndex |
very low density lipoprotein |
dc.subject.otherIndex |
abdominal obesity |
dc.subject.otherIndex |
adult |
dc.subject.otherIndex |
article |
dc.subject.otherIndex |
carbohydrate intake |
dc.subject.otherIndex |
cardiovascular risk |
dc.subject.otherIndex |
catabolism |
dc.subject.otherIndex |
clinical trial |
dc.subject.otherIndex |
controlled clinical trial |
dc.subject.otherIndex |
controlled study |
dc.subject.otherIndex |
double blind procedure |
dc.subject.otherIndex |
dyslipidemia |
dc.subject.otherIndex |
energy expenditure |
dc.subject.otherIndex |
fat intake |
dc.subject.otherIndex |
glucose blood level |
dc.subject.otherIndex |
glucose homeostasis |
dc.subject.otherIndex |
human |
dc.subject.otherIndex |
hypertriglyceridemia |
dc.subject.otherIndex |
insulin blood level |
dc.subject.otherIndex |
insulin sensitivity |
dc.subject.otherIndex |
male |
dc.subject.otherIndex |
metabolic syndrome x |
dc.subject.otherIndex |
postprandial state |
dc.subject.otherIndex |
priority journal |
dc.subject.otherIndex |
protein blood level |
dc.subject.otherIndex |
protein intake |
dc.subject.otherIndex |
randomized controlled trial |
dc.subject.otherIndex |
adult |
dc.subject.otherIndex |
apolipoprotein a-i |
dc.subject.otherIndex |
blood glucose |
dc.subject.otherIndex |
cholesterol, hdl |
dc.subject.otherIndex |
cross-over studies |
dc.subject.otherIndex |
dietary carbohydrates |
dc.subject.otherIndex |
dietary fats |
dc.subject.otherIndex |
dietary proteins |
dc.subject.otherIndex |
double-blind method |
dc.subject.otherIndex |
dyslipidemias |
dc.subject.otherIndex |
ghrelin |
dc.subject.otherIndex |
humans |
dc.subject.otherIndex |
hypertriglyceridemia |
dc.subject.otherIndex |
insulin |
dc.subject.otherIndex |
interleukin-6 |
dc.subject.otherIndex |
male |
dc.subject.otherIndex |
metabolic syndrome x |
dc.subject.otherIndex |
obesity, abdominal |
dc.subject.otherIndex |
peptide yy |
dc.subject.otherIndex |
postprandial period |
dc.subject.otherKeywordPlus |
Density lipoprotein secretion |
dc.subject.otherKeywordPlus |
coronary-artery-disease |
dc.subject.otherKeywordPlus |
apolipoprotein-a-ii |
dc.subject.otherKeywordPlus |
adipose-tissue |
dc.subject.otherKeywordPlus |
insulin-resistance |
dc.subject.otherKeywordPlus |
lipase activity |
dc.subject.otherKeywordPlus |
hdl metabolism |
dc.subject.otherKeywordPlus |
zucker rats |
dc.subject.otherKeywordPlus |
weight-loss |
dc.subject.otherKeywordPlus |
syndrome-x |
dc.subject.otherWOS |
Peripheral Vascular Disease |
dc.identifier.doi |
http://dx.doi.org/10.1016/j.atherosclerosis.2009.11.017 |